William Ashton - Net Worth and Insider Trading
William Ashton Net Worth
The estimated net worth of William Ashton is at least $333,924 dollars as of 2024-09-20. William Ashton is the Director of Societal CDMO Inc and owns about 263,622 shares of Societal CDMO Inc (SCTL) stock worth over $289,984. William Ashton is the Director of Spectrum Pharmaceuticals Inc and owns about 42,660 shares of Spectrum Pharmaceuticals Inc (SPPI) stock worth over $43,940. William Ashton is also the Director of Sucampo Pharmaceuticals Inc and owns about 0 shares of Sucampo Pharmaceuticals Inc (SCMP) stock worth over $0. Details can be seen in William Ashton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William Ashton has not made any transactions after 2023-08-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William Ashton
William Ashton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William Ashton owns 5 companies in total, including Spectrum Pharmaceuticals Inc (SPPI) , Societal CDMO Inc (SCTL) , and Baudax Bio Inc (BXRXQ) among others .
Click here to see the complete history of William Ashton’s form 4 insider trades.
Insider Ownership Summary of William Ashton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SPPI | Spectrum Pharmaceuticals Inc | 2023-07-31 | director |
| SCTL | Societal CDMO Inc | 2023-08-28 | director |
| BXRXQ | Baudax Bio Inc | 2022-06-15 | director |
 | | 2013-04-26 | director |
| | 2015-03-12 | director |
William Ashton Latest Holdings Summary
William Ashton currently owns a total of 3 stocks. Among these stocks, William Ashton owns 263,622 shares of Societal CDMO Inc (SCTL) as of August 28, 2023, with a value of $289,984 and a weighting of 86.84%. William Ashton owns 42,660 shares of Spectrum Pharmaceuticals Inc (SPPI) as of June 21, 2022, with a value of $43,940 and a weighting of 13.16%. William Ashton also owns 0 shares of Sucampo Pharmaceuticals Inc (SCMP) as of March 12, 2015, with a value of $0 and a weighting of 0%.
Latest Holdings of William Ashton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SCTL | Societal CDMO Inc | 2023-08-28 | 263,622 | 1.10 | 289,984 |
| SPPI | Spectrum Pharmaceuticals Inc | 2022-06-21 | 42,660 | 1.03 | 43,940 |
| SCMP | Sucampo Pharmaceuticals Inc | 2015-03-12 | 0 | 18.00 | 0 |
Holding Weightings of William Ashton
William Ashton Form 4 Trading Tracker
According to the SEC Form 4 filings, William Ashton has made a total of 1 transactions in Societal CDMO Inc (SCTL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Societal CDMO Inc is the acquisition of 22,222 shares on August 28, 2023, which cost William Ashton around $10,222.
According to the SEC Form 4 filings, William Ashton has made a total of 2 transactions in Spectrum Pharmaceuticals Inc (SPPI) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Spectrum Pharmaceuticals Inc is the sale of 4,283 shares on June 21, 2022, which brought William Ashton around $3,384.
According to the SEC Form 4 filings, William Ashton has made a total of 0 transactions in Sucampo Pharmaceuticals Inc (SCMP) over the past 5 years. The most-recent trade in Sucampo Pharmaceuticals Inc is the sale of 129,766 shares on March 12, 2015, which brought William Ashton around $2 Million.
Insider Trading History of William Ashton
- 1
William Ashton Trading Performance
GuruFocus tracks the stock performance after each of William Ashton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William Ashton is -13.27%. GuruFocus also compares William Ashton's trading performance to market benchmark return within the same time period. The performance of stocks bought by William Ashton within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William Ashton's insider trading performs compared to the benchmark.
Performance of William Ashton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.22 | | | | | |
| Relative Return to S&P 500(%) | 5.23 | | | | | |
William Ashton Ownership Network
William Ashton Owned Company Details
What does Spectrum Pharmaceuticals Inc do?
Who are the key executives at Spectrum Pharmaceuticals Inc?
William Ashton is the director of Spectrum Pharmaceuticals Inc. Other key executives at Spectrum Pharmaceuticals Inc include See Remarks Nora Brennan , Chief Legal Officer Keith M Mcgahan , and director & CEO & President Thomas J Riga .
Spectrum Pharmaceuticals Inc (SPPI) Insider Trades Summary
Over the past 18 months, William Ashton made no insider transaction in Spectrum Pharmaceuticals Inc (SPPI). Other recent insider transactions involving Spectrum Pharmaceuticals Inc (SPPI) include a net sale of 32,387 shares made by Nora Brennan ,
In summary, during the past 3 months, insiders sold 0 shares of Spectrum Pharmaceuticals Inc (SPPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,387 shares of Spectrum Pharmaceuticals Inc (SPPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 32,387 shares.
Spectrum Pharmaceuticals Inc (SPPI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spectrum Pharmaceuticals Inc Insider Transactions
William Ashton Mailing Address
Above is the net worth, insider trading, and ownership report for William Ashton. You might contact William Ashton via mailing address: C/o Harrison Consulting Group, Po Box 283, Newtown Square Pa 19073.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
